Most genetic analyses of prostate cancer have studied white men. A new study compares the genetic landscape of prostate cancer in Chinese men, reporting both similarities and differences. This finding highlights the need for studies to include all races and paves the way for future personalized medicine approaches for prostate cancer across races.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer
Scientific Reports Open Access 18 October 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
National Human Genome Research Institute. The cost of sequencing a human genome. National Institutes of Health https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome (2016).
Venter, J. C. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7–30 (2017).
Ren, S. et al. Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2017.08.027 (2017).
Farrell, J. et al. Predominance of ERG-negative high-grade prostate cancers in African American men. Mol. Clin. Oncol. 2, 982–986 (2014).
Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).
Zhao, S. G. et al. Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy. JAMA Oncol. http://dx.doi.org/10.1001/jamaoncol.2017.0751 (2017).
You, S. et al. Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome. Cancer Res. 76, 4948–4958 (2016).
Pettersson, A. et al. Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. J. Natl Cancer Inst. 105, 1881–1890 (2013).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02465060 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Freedland, S. Race and prostate cancer personalized medicine: the future. Nat Rev Urol 15, 207–208 (2018). https://doi.org/10.1038/nrurol.2017.215
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.215
